Manjiri Kiran Dighe

Prof. Manjiri Kiran Dighe


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in RadioGraphics
Verified
Journal Article
Closed access
SFShaimaa Fadl
Shaimaa Fadl
MMMariam Moshiri
Mariam Moshiri
CFCorinne L. Fligner
Corinne L. Fligner
DKDouglas S. Katz
Douglas S. Katz
MDManjiri Kiran Dighe
Manjiri Kiran Dighe
A comprehensive imaging review of early placental formation, normal placental imaging features, and various placental pathologic conditions is provided, with discussion of newer imaging techniques for evaluation of the placenta. The placenta plays a crucial role throughout pregnancy, and its importance may be overlooked during routine antenatal imaging evaluation. Detailed systematic assessment of the placenta at ultrasonography (US), the standard imaging examination during pregnancy, is important. Familiarity with the normal and abnormal imaging appearance of the placenta along with the multimodality and methodical approach for evaluation of its related abnormalities is necessary, so that radiologists can alert clinicians regarding appropriate prompt management decisions. This will potentially decrease fetal and maternal morbidity and mortality. This article reviews early placental formation and the expected imaging appearance of the placenta during pregnancy, as well as variations in its morphology. It also discusses various placental diseases and their potential clinical consequences. Placental pathologic conditions include abnormalities of placental size, cord insertion, placental and cord location, and placental adherence. O...

1 January 2014 in European Journal of Radiology Open
Verified
Journal Article
Open access
SMSuresh Maximin
Suresh Maximin
Dhakshinamoorthy GaneshanDhakshinamoorthy Ganeshan
Dhakshinamoorthy Ganeshan
ASAlampady K. Shanbhogue
Alampady K. Shanbhogue
MDManjiri Kiran Dighe
Manjiri Kiran Dighe
MYMatthew M. Yeh
Matthew M. Yeh
NLNeeraj Lalwani
Neeraj Lalwani
Combined hepatocellular-cholangiocarcinoma is a rare but unique primary hepatic tumor with characteristic histology and tumor biology. Recent development in genetics and molecular biology support the fact that combined hepatocellular-cholangiocarcinoma is closely linked with cholangiocarcinoma, rather than hepatocellular carcinoma. Combined hepatocellular cholangiocarcinoma tends to present with an more aggressive behavior and a poorer prognosis than either hepatocellular carcinoma or cholangiocarcinoma. An accurate preoperative diagnosis and aggressive treatment planning can play crucial roles in appropriate patient management.

26 July 2015 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
MIMalak Itani
Malak Itani
AKAnia Kielar
Ania Kielar
CMChristine O. Menias
Christine O. Menias
MDManjiri Kiran Dighe
Manjiri Kiran Dighe
VSVenkateswar Surabhi
Venkateswar Surabhi
NLNeeraj Lalwani
Neeraj Lalwani

1 March 2021 in Radiology
Verified
Journal Article
Closed access
JXJennifer M. Xiao
Jennifer M. Xiao
DHDaniel S Hippe
Daniel S Hippe
MZMladen Zečević
Mladen Zečević
DZDavid A. Zamora
David A. Zamora
LCLarry M. Cai
Larry M. Cai
AMAchille Mileto
Achille Mileto
Virtual unenhanced images from a dual-energy CT multimaterial decomposition algorithm yield renal mass attenuation comparable to true unenhanced images for both enhancing renal masses and nonenhanc... Background Virtual unenhanced (VUE) images obtained by using a dual-energy CT (DECT) multimaterial decomposition algorithm hold promise for diagnostic use in the abdomen in lieu of true unenhanced ...

22 December 2015 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
KGKiran Gangadhar
Kiran Gangadhar
AKAnia Kielar
Ania Kielar
MDManjiri Kiran Dighe
Manjiri Kiran Dighe
RORyan O’malley
Ryan O’malley
CWCarolyn Wang
Carolyn Wang
NLNeeraj Lalwani
Neeraj Lalwani

8 September 2023 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
NPNikita Pozdeyev
Nikita Pozdeyev
MDManjiri Kiran Dighe
Manjiri Kiran Dighe
MBMartin Barrio
Martin Barrio
CRChristopher Raeburn
Christopher Raeburn
HSHarry A Smith
Harry A Smith
TCTrevor Cohen
Trevor Cohen
Context: Thyroid nodule ultrasound-based risk stratification schemas rely on the presence of high-risk sonographic features. However, some malignant thyroid nodules have benign appearance on thyroid ultrasound. New methods for thyroid nodule risk assessment are needed. Objective: We investigated polygenic risk score (PRS) accounting for inherited thyroid cancer risk combined with ultrasound-based analysis for improved thyroid nodule risk assessment. Methods: The convolutional neural network classifier was trained on thyroid ultrasound still images and cine clips from 621 thyroid nodules. Phenome-wide association study (PheWAS) and PRS PheWAS were used to optimize PRS for distinguishing benign and malignant nodules. PRS was evaluated in 73 346 participants in the Colorado Center for Personalized Medicine Biobank. Results: When the deep learning model output was combined with thyroid cancer PRS and genetic ancestry estimates, the area under the receiver operating characteristic curve (AUROC) of the benign vs malignant thyroid nodule classifier increased from 0.83 to 0.89 (DeLong, P value = .007). The combined deep learning and genetic classifier achieved a clinically relevant sensitivity of 0.95, 95% CI [0.88-0.99], specificity of 0.63 [0.55-0.70], and positive and negative predictive values of 0.47 [0.41-0.58] and 0.97 [0.92-0.99], respectively. AUROC improvement was consistent in European ancestry-stratified analysis (0.83 and 0.87 for deep learning and deep learning combined with PRS classifiers, respectively). Elevated PRS was associated with a greater risk of thyroid cancer structural disease recurrence (ordinal logistic regression, P value = .002). Conclusion: Augmenting ultrasound-based risk assessment with PRS improves diagnostic accuracy.